Banerjee, Rahul http://orcid.org/0000-0003-3781-5441
Wang, Victoria
Huang, Chiung-Yu
Pandita, Divita
Leonard, Michelle K.
LaRue, Siobhan
Ahmadi, Michael
Kaplan, Lawrence
Ai, Weiyun Z.
Fakhri, Bita
Spinner, Michael
Seshadri, Madhav Rao
Pampaloni, Miguel Hernandez
Andreadis, Charalambos Babis
Funding for this research was provided by:
Department of Medicine, University of California, San Francisco (RAP Award)
Division of Cancer Prevention, National Cancer Institute (K08CA249744)
Conquer Cancer Foundation (ASCO Conquer Cancer Foundation Career Development Award)
Article History
Received: 24 March 2023
Accepted: 5 June 2023
First Online: 10 June 2023
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Our study was reviewed and approved by the University of California San Francisco Institutional Review Board. Informed consent was obtained from all individual participants included in the study. The authors affirm that human research participants provided informed consent for the publication of the images in Fig. InternalRef removed.
: RB: Consulting: BMS, Caribou Biosciences, Genentech, Janssen, Pfizer, Sanofi, SparkCures; research support: Pack Health. VW: Research support: Inhibrx. WZA: Consulting: Kite, ADC, More Health, Secura Bio, Kyowa. BF: Consulting: Abbvie, Adaptive, AstraZeneca, BeiGene, BMS, CurioScience, Genentech, Genmab, Loxo/Lilly, Medscape, Pharmacyclics, TG Therapeutics; Research support: Abbvie, BMS, Genmab, Loxo/Lilly. MS: Consulting: Gilead, Kite. MRS: Consulting: Beigene, Gilead; research support: Eli Lilly, Roche. CA: Consulting: BMS, Gilead; Research support: BMS, Novartis. Remaining authors: none.